EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liver-specific glucagon dysfunction promotes PP-cell hyperplasia and formation of glucagon and PP double-positive cells

Yuko Nakagawa, Takuro Horii, Ayako Fukunaka, Takashi Sato, Zhehao Zhang, Masaki Kobayashi, Tadahiro Kitamura, Yoshitaka Hayashi, Takashi Nishimura, Izuho Hatada, Yoshio Fujitani iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0329094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yuko Nakagawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Developmental Biology and Metabolism, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Maebashi, Japan. Hauptthemen laut MEDLINE: Glucagon, Liver, Glucagon-Secreting Cells, Pancreatic Polypeptide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology, Japan, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the mechanisms that regulate cell identity acquisition and cell proliferation is crucial, not only for elucidating cellular functions but also for clarifying the pathogenesis of various diseases, including neoplasms. Pancreatic endocrine cells typically express a single hormone, and their numbers are tightly regulated. Contrary to this general principle, in this study, we found that proglucagon-deficient mice exhibit a significant increase in the number of glucagon (GCG) and pancreatic polypeptide (PP) double-positive cells (GCG + PP + cells), together with the hyperplasia of both PP and α cells. Similarly, glucagon receptor-deficient mice displayed PP-cell hyperplasia and an increased number of GCG + PP + cells, with PP-cell replication implicated in this process. mTOR signaling was activated in GCG + PP + cells, suggesting its involvement in endocrine differentiation. Furthermore, impaired hepatic GCG signaling led to elevated plasma amino acid levels, which in turn promoted pancreatic endocrine cell proliferation and disrupted the maintenance of cellular identity in mice. Moreover, we found that increased glutamine levels promote GCG + PP + cell formation via mTOR signaling, revealing a novel regulatory mechanism underlying pancreatic endocrine cell plasticity. These findings provide new insights into endocrine cell regulation, and may contribute to a better understanding of pancreatic neuroendocrine tumor development, as well as the identification of novel therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucagonLiverGlucagon-Secreting CellsPancreatic PolypeptidePancreatic Polypeptide-Secreting CellsAnimalsHyperplasiaMiceCell ProliferationSignal TransductionTOR Serine-Threonine KinasesReceptors, GlucagonMice, KnockoutProglucagonGlutamineMice, Inbred C57BL

Substanzen

GlucagonTOR Serine-Threonine KinasesReceptors, GlucagonPancreatic PolypeptideProglucagonmTOR protein, mouseGlutamine

Autor:innen und Institutionen

  • Laboratory of Developmental Biology and Metabolism, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Maebashi, Japan.
  • Laboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
  • Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
  • Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
  • Laboratory of Metabolic Regulation and Genetics, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

ORCID-Profile: Yoshio Fujitani

Förderung

  • Ministry of Education, Culture, Sports, Science, and Technology, Japan
  • Takeda Science Foundation

Zitieren

APA

Nakagawa, Y., Horii, T., Fukunaka, A., Sato, T., Zhang, Z., Kobayashi, M., Kitamura, T., Hayashi, Y., Nishimura, T., Hatada, I., & Fujitani, Y. (2025). Liver-specific glucagon dysfunction promotes PP-cell hyperplasia and formation of glucagon and PP double-positive cells. PLOS One. https://doi.org/10.1371/journal.pone.0329094

Vancouver

Nakagawa Y, Horii T, Fukunaka A, Sato T, Zhang Z, Kobayashi M, et al. Liver-specific glucagon dysfunction promotes PP-cell hyperplasia and formation of glucagon and PP double-positive cells. PLOS One. 2025. doi:10.1371/journal.pone.0329094

BibTeX
@article{Nakagawa2025,
  author = {Nakagawa, Yuko and Horii, Takuro and Fukunaka, Ayako and Sato, Takashi and Zhang, Zhehao and Kobayashi, Masaki and Kitamura, Tadahiro and Hayashi, Yoshitaka and Nishimura, Takashi and Hatada, Izuho and Fujitani, Yoshio},
  title = {Liver-specific glucagon dysfunction promotes PP-cell hyperplasia and formation of glucagon and PP double-positive cells},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0329094}
}
Kostenlos starten →